Satya P. Sharma
Chuncheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Synbiotic combination of fructooligosaccharides and probiotics ameliorates the metabolic dysfunction-associated steatotic liver disease.
Journal: Journal of microbiology (Seoul, Korea)
Published: November 02, 2024
Correspondence to editorial on: "Gut microbiome and metabolome signatures in liver cirrhosis-related complications".
Journal: Clinical and molecular hepatology
Published: October 04, 2024
Gut microbiome and metabolome signatures in liver cirrhosis-related complications.
Journal: Clinical and molecular hepatology
Published: May 10, 2024
A consortium of Hordeum vulgare and gut microbiota against non-alcoholic fatty liver disease via data-driven analysis.
Journal: Artificial cells, nanomedicine, and biotechnology
Published: April 30, 2024
Multistrain Probiotics Alleviate Diarrhea by Modulating Microbiome-Derived Metabolites and Serotonin Pathway.
Journal: Probiotics and antimicrobial proteins
Published: February 02, 2024
Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation.
Journal: Gut microbes
Published: February 01, 2024
Microbial influence on liver regeneration: understanding gut microbiota and hepatic recovery post partial hepatectomy.
Journal: Hepatobiliary surgery and nutrition
Published: December 15, 2023
New insight of chemical constituents in Persea americana fruit against obesity via integrated pharmacology.
Journal: Clinical and translational science
Published: November 27, 2023
Gut-microbiota prompt activation of natural killer cell on alcoholic liver disease.
Journal: Gut microbes
Published: November 21, 2023
The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysis.
Journal: Artificial cells, nanomedicine, and biotechnology
Published: May 02, 2023
A metabolomics approach to the validation of predictive metabolites and phenotypic expression in non-alcoholic fatty liver disease.
Journal: Life sciences
Published: February 14, 2023
Last Updated: 09/26/2026